Histogen, Inc. - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/382553.xml Histogen, Inc. - Press Releases en xml@emediawire.com xml@emediawire.com 30 Histogen Announces Start of Hair Regrowth Clinical Evaluation http://www.prweb.com/releases/Histogen/HairStudy/prweb1643564.htm Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced the start of the Company's first human clinical evaluation of ReGenica for hair regrowth. ReGenica is the first naturally stabilized and bioactive formulation of wnt proteins and natural cofactors, which are thought to act in the formation of new hair follicles. (PRWeb Nov 20, 2008)

Read the full story at http://www.prweb.com/releases/Histogen/HairStudy/prweb1643564.htm

]]> http://www.prweb.com/releases/Histogen/HairStudy/prweb1643564.htm Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine http://www.prweb.com/releases/Histogen/CommTranslations/prweb1620614.htm ExCeltrix Preliminary Oncology Data Presented for the First Time (PRWeb Nov 17, 2008)

Read the full story at http://www.prweb.com/releases/Histogen/CommTranslations/prweb1620614.htm

]]> http://www.prweb.com/releases/Histogen/CommTranslations/prweb1620614.htm Recognized Dermatology Expert Dr. Zoe Draelos Joins Histogen Scientific Advisory Board http://www.prweb.com/releases/Histogen/Draelos/prweb1609104.htm Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced that Zoe Diane Draelos, M.D., clinical and research dermatologist and President of Dermatology Consulting Services, has joined the Company's Scientific Advisory Board. (PRWeb Nov 13, 2008)

Read the full story at http://www.prweb.com/releases/Histogen/Draelos/prweb1609104.htm

]]> http://www.prweb.com/releases/Histogen/Draelos/prweb1609104.htm Histogen Aesthetics is Created to Address Growing Medical Aesthetics Market http://www.prweb.com/releases/Histogen/Aesthetics/prweb1490564.htm Dr. Lawrence A. Rheins Joins Histogen Aesthetics as President (PRWeb Oct 20, 2008)

Read the full story at http://www.prweb.com/releases/Histogen/Aesthetics/prweb1490564.htm

]]> http://www.prweb.com/releases/Histogen/Aesthetics/prweb1490564.htm Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit http://www.prweb.com/releases/BioNuesis/Histogen/prweb1355104.htm Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today launched BioNuesisTM, the only soluble human extracellular matrix (ECM) developed as a culturing kit for stem cell growth. The kit was launched and is being exhibited at the 2008 World Stem Cell Summit taking place in Madison, Wisconsin. (PRWeb Sep 22, 2008)

Read the full story at http://www.prweb.com/releases/BioNuesis/Histogen/prweb1355104.htm

]]> http://www.prweb.com/releases/BioNuesis/Histogen/prweb1355104.htm Histogen Presents Feasibility Data on Hair Growth and Laser Resurfacing http://www.prweb.com/releases/data/Histogen/prweb947154.htm Evaluations of HGEN-001 formulation indicate capabilities for new hair follicle creation and more rapid healing post-laser resurfacing. (PRWeb May 16, 2008)

Read the full story at http://www.prweb.com/releases/data/Histogen/prweb947154.htm

]]> http://www.prweb.com/releases/data/Histogen/prweb947154.htm Histogen Announces Initial Close of Series A Financing Round http://www.prweb.com/releases/2008/05/prweb908944.htm Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced the initial close of Series A financing at $5.35 million. (PRWeb May 2, 2008)

Read the full story at http://www.prweb.com/releases/2008/05/prweb908944.htm

]]> http://www.prweb.com/releases/2008/05/prweb908944.htm Alberto-Culver Founder Leonard Lavin Joins Histogen Board of Directors http://www.prweb.com/releases/2008/02/prweb700134.htm Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced that Leonard Lavin, founder and chairman emeritus of the Alberto-Culver Company, has joined Histogen's Board of Directors. (PRWeb Feb 15, 2008)

Read the full story at http://www.prweb.com/releases/2008/02/prweb700134.htm

]]> http://www.prweb.com/releases/2008/02/prweb700134.htm